Concepedia

Publication | Open Access

Sarilumab use in severe SARS-CoV-2 pneumonia

DOIFull Paper Access

73

Citations

22

References

2020

Year

Elisa Gremese, Antonella Cingolani, Silvia Laura Bosello, Stefano Alivernini, Barbara Tolusso, Simone Perniola, Francesco Landi, Maurizio Pompili, Rita Murri, Angelo Santoliquido,
EClinicalMedicine

Abstract

IL-6R inhibition appears to be a potential treatment strategy for severe SARS-CoV-2 pneumonia and intravenous Sarilumab seems a promising treatment approach showing, in the short term, an important clinical outcome and good safety.

References

YearCitations

Page 1